The local dinucleotide preference of APOBEC3G can be altered from 5′-CC to 5′-TC by a single amino acid substitution

Journal of Molecular Biology

Volumn 425, Issue 22, 2013, Pages 4442-4454

  Rathore, Anurag ^a   Carpenter, Michael A ^a   Demir, Özlem ^b   Ikeda, Terumasa ^a   Li, Ming ^a   Shaban, Nadine M ^a   Law, Emily K ^a   Anokhin, Dmitry ^a   Brown, William L ^a   Amaro, Rommie E ^b   Harris, Reuben S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

APOBEC3A; APOBEC3G; DNA cytosine deamination; HIV 1 restriction; local dinucleotide target selection

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; COMPLEMENTARY DNA; CYTOSINE; CYTOSINE DEAMINASE; DINUCLEOTIDE; SINGLE STRANDED DNA; THYMINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CATALYSIS; CHIMERA; DEAMINATION; DNA BINDING; DNA RESTRICTION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84886725548     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2013.07.040     Document Type: Article

References (81)

1. S. Longerich, U. Basu, F. Alt, and U. Storb AID in somatic hypermutation and class switch recombination Curr Opin Immunol 18 2006 164 174
2. J.M. Di Noia, and M.S. Neuberger Molecular mechanisms of antibody somatic hypermutation Annu Rev Biochem 76 2007 1 22
3. R.S. Harris, S.K. Petersen-Mahrt, and M.S. Neuberger RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators Mol Cell 10 2002 1247 1253
4. V. Blanc, and N.O. Davidson C-to-U RNA editing: mechanisms leading to genetic diversity J Biol Chem 278 2003 1395 1398
5. V. Petit, D. Guetard, M. Renard, A. Keriel, M. Sitbon, and S. Wain-Hobson Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo J Mol Biol 385 2009 65 78
6. M. Cervantes Gonzalez, R. Suspene, M. Henry, D. Guetard, S. Wain-Hobson, and J.P. Vartanian Human APOBEC1 cytidine deaminase edits HBV DNA Retrovirology 6 2009 96
7. T. Ikeda, K.H. Abd El Galil, K. Tokunaga, K. Maeda, T. Sata, and N. Sakaguchi Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons Nucleic Acids Res 39 2011 5538 5554
8. T. Ikeda, T. Ohsugi, T. Kimura, S. Matsushita, Y. Maeda, and S. Harada The antiretroviral potency of APOBEC1 deaminase from small animal species Nucleic Acids Res 36 2008 6859 6871
9. A.M. Niewiadomska, C. Tian, L. Tan, T. Wang, P.T. Sarkis, and X.F. Yu Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association J Virol 81 2007 9577 9583
10. M.H. Malim, and M. Emerman HIV-1 accessory proteins - ensuring viral survival in a hostile environment Cell Host Microbe 3 2008 388 398
11. J.S. Albin, and R.S. Harris Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics Expert Rev Mol Med 12 2010 e4
12. S. Wissing, N.L. Galloway, and W.C. Greene HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors Mol Aspects Med 31 2010 383 397
13. R.S. Harris, J.F. Hultquist, and D.T. Evans The restriction factors of human immunodeficiency virus J Biol Chem 287 2012 40875 40883
14. A.M. Niewiadomska, and X.F. Yu Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif Curr Top Microbiol Immunol 339 2009 1 25
15. R.S. Harris, K.N. Bishop, A.M. Sheehy, H.M. Craig, S.K. Petersen-Mahrt, and I.N. Watt DNA deamination mediates innate immunity to retroviral infection Cell 113 2003 803 809
16. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 424 2003 99 103
17. H. Zhang, B. Yang, R.J. Pomerantz, C. Zhang, S.C. Arunachalam, and L. Gao The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA Nature 424 2003 94 98
18. K.N. Bishop, R.K. Holmes, A.M. Sheehy, N.O. Davidson, S.J. Cho, and M.H. Malim Cytidine deamination of retroviral DNA by diverse APOBEC proteins Curr Biol 14 2004 1392 1396
19. M.T. Liddament, W.L. Brown, A.J. Schumacher, and R.S. Harris APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo Curr Biol 14 2004 1385 1391
20. H.L. Wiegand, B.P. Doehle, H.P. Bogerd, and B.R. Cullen A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins EMBO J 23 2004 2451 2458
21. Y.-H. Zheng, D. Irwin, T. Kurosu, K. Tokunaga, T. Sata, and B.M. Peterlin Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication J Virol 78 2004 6073 6076
22. C. Rosler, J. Kock, M. Kann, M.H. Malim, H.E. Blum, and T.F. Baumert APOBEC-mediated interference with hepadnavirus production Hepatology 42 2005 301 309
23. H. Chen, C.E. Lilley, Q. Yu, D.V. Lee, J. Chou, and I. Narvaiza APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons Curr Biol 16 2006 480 485
24. M. Bonvin, F. Achermann, I. Greeve, D. Stroka, A. Keogh, and D. Inderbitzin Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication Hepatology 43 2006 1364 1374
25. T.F. Baumert, C. Rosler, M.H. Malim, and F. von Weizsacker Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C Hepatology 46 2007 682 689
26. J.P. Vartanian, D. Guetard, M. Henry, and S. Wain-Hobson Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions Science 320 2008 230 233
27. M. Henry, D. Guetard, R. Suspene, C. Rusniok, S. Wain-Hobson, and J.P. Vartanian Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G PLoS One 4 2009 e4277
28. J. Kock, and H.E. Blum Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H J Gen Virol 89 2008 1184 1191
29. F. Delebecque, R. Suspene, S. Calattini, N. Casartelli, A. Saib, and A. Froment Restriction of foamy viruses by APOBEC cytidine deaminases J Virol 80 2006 605 614
30. S. Gunther, G. Sommer, U. Plikat, A. Iwanska, S. Wain-Hobson, and H. Will Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G → A hypermutation Virology 235 1997 104 108
31. R. Mahieux, R. Suspene, F. Delebecque, M. Henry, O. Schwartz, and S. Wain-Hobson Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases J Gen Virol 86 2005 2489 2494
32. R. Suspène, D. Guétard, M. Henry, P. Sommer, S. Wain-Hobson, and J.P. Vartanian Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo Proc Natl Acad Sci USA 102 2005 8321 8326
33. M. Ooms, A. Krikoni, A.K. Kress, V. Simon, and C. Munk APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1 J Virol 86 2012 6097 6108
34. Q. Yu, R. Konig, S. Pillai, K. Chiles, M. Kearney, and S. Palmer Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome Nat Struct Mol Biol 11 2004 435 442
35. L. Chelico, P. Pham, P. Calabrese, and M.F. Goodman APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA Nat Struct Mol Biol 13 2006 392 399
36. J.F. Hultquist, J.A. Lengyel, E.W. Refsland, R.S. LaRue, L. Lackey, and W.L. Brown Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1 J Virol 85 2011 11220 11234
37. E.W. Refsland, J.F. Hultquist, and R.S. Harris Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n PLoS Pathog 8 2012 e1002800
38. M.D. Stenglein, M.B. Burns, M. Li, J. Lengyel, and R.S. Harris APOBEC3 proteins mediate the clearance of foreign DNA from human cells Nat Struct Mol Biol 17 2010 222 229
39. R. Suspène, M.M. Aynaud, D. Guetard, M. Henry, G. Eckhoff, and A. Marchio Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism Proc Natl Acad Sci USA 108 2011 4858 4863
40. Y. Bulliard, I. Narvaiza, A. Bertero, S. Peddi, U.F. Rohrig, and M. Ortiz Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities J Virol 85 2011 1765 1776
41. M.A. Carpenter, M. Li, A. Rathore, L. Lackey, E.K. Law, and A.M. Land Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A J Biol Chem 287 2012 34801 34808
42. B.K. Thielen, J.P. McNevin, M.J. McElrath, B.V. Hunt, K.C. Klein, and J.R. Lingappa Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms J Biol Chem 285 2010 27753 27766
43. F.A. Koning, E.N. Newman, E.Y. Kim, K.J. Kunstman, S.M. Wolinsky, and M.H. Malim Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets J Virol 83 2009 9474 9485
44. E.W. Refsland, M.D. Stenglein, K. Shindo, J.S. Albin, W.L. Brown, and R.S. Harris Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction Nucleic Acids Res 38 2010 4274 4284
45. P. Wijesinghe, and A.S. Bhagwat Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3G Nucleic Acids Res 40 2012 9206 9217
46. G. Berger, S. Durand, G. Fargier, X.N. Nguyen, S. Cordeil, and S. Bouaziz APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells PLoS Pathog 7 2011 e1002221
47. F.A. Koning, C. Goujon, H. Bauby, and M.H. Malim Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages J Virol 85 2011 13448 13452
48. S.G. Conticello The AID/APOBEC family of nucleic acid mutators Genome Biol 9 2008 229
49. R.S. LaRue, V. Andresdottir, Y. Blanchard, S.G. Conticello, D. Derse, and M. Emerman Guidelines for naming nonprimate APOBEC3 genes and proteins J Virol 83 2009 494 497
50. M.A. Langlois, R.C. Beale, S.G. Conticello, and M.S. Neuberger Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities Nucleic Acids Res 33 2005 1913 1923
51. R.M. Kohli, S.R. Abrams, K.S. Gajula, R.W. Maul, P.J. Gearhart, and J.T. Stivers A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase J Biol Chem 284 2009 22898 22904
52. M.A. Carpenter, E. Rajagurubandara, P. Wijesinghe, and A.S. Bhagwat Determinants of sequence-specificity within human AID and APOBEC3G DNA Repair 9 2010 579 587
53. M. Wang, C. Rada, and M.S. Neuberger Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID J Exp Med 207 2010 141 153
54. R.M. Kohli, R.W. Maul, A.F. Guminski, R.L. McClure, K.S. Gajula, and H. Saribasak Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification J Biol Chem 285 2010 40956 40964
55. H.C. Losey, A.J. Ruthenburg, and G.L. Verdine Crystal structure of Staphylococcus aureus tRNA adenosine deaminase TadA in complex with RNA Nat Struct Mol Biol 13 2006 153 159
56. S.G. Conticello, M.A. Langlois, and M.S. Neuberger Insights into DNA deaminases Nat Struct Mol Biol 14 2007 7 9
57. M.A. Larkin, G. Blackshields, N.P. Brown, R. Chenna, P.A. McGettigan, and H. McWilliam Clustal W and Clustal X version 2.0 Bioinformatics 23 2007 2947 2948
58. M. Henry, C. Terzian, M. Peeters, S. Wain-Hobson, and J.P. Vartanian Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions PLoS One 7 2012 e30036
59. K. Schmitt, K. Guo, M. Algaier, A. Ruiz, F. Cheng, and J. Qiu Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution Virology 419 2011 24 42
60. S.M.D. Shandilya, M.N.L. Nalam, E.A. Nalivaika, P.J. Gross, J.C. Valesano, and K. Shindo Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces Structure 18 2010 28 38
61. I.J. Byeon, J. Ahn, M. Mitra, C.H. Byeon, K. Hercik, and J. Hritz NMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificity Nat Commun 4 2013 1890
62. B.K. Thielen, K.C. Klein, L.W. Walker, M. Rieck, J.H. Buckner, and G.W. Tomblingson T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity PLoS Pathog 3 2007 1320 1334
63. M. Li, S.M. Shandilya, M.A. Carpenter, A. Rathore, W.L. Brown, and A.L. Perkins First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G ACS Chem Biol 7 2012 506 517
64. A.J. Schumacher, G. Haché, D.A. MacDuff, W.L. Brown, and R.S. Harris The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction J Virol 82 2008 2652 2660
65. E. Miyagi, S. Opi, H. Takeuchi, M. Khan, R. Goila-Gaur, and S. Kao Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1 J Virol 81 2007 13346 13353
66. E.P. Browne, C. Allers, and N.R. Landau Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent Virology 387 2009 313 321
67. R.K. Holmes, M.H. Malim, and K.N. Bishop APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci 32 2007 118 128
68. R. Aurora, and G.D. Rose Helix capping Protein Sci 7 1998 21 38
69. M.J. Bodkin, and J.M. Goodfellow Competing interactions contributing to alpha-helical stability in aqueous solution Protein Sci 4 1995 603 612
70. A.J. Doig, and R.L. Baldwin N- and C-capping preferences for all 20 amino acids in alpha-helical peptides Protein Sci 4 1995 1325 1336
71. S.K. Petersen-Mahrt, R.S. Harris, and M.S. Neuberger AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification Nature 418 2002 99 103
72. M.E. Olson, M. Li, R.S. Harris, and D.A. Harki Small-molecule APOBEC3G DNA cytosine deaminase inhibitors based on a 4-amino-1,2,4-triazole-3-thiol scaffold ChemMedChem 8 2013 112 117
73. M.B. Burns, L. Lackey, M.A. Carpenter, A. Rathore, A.M. Land, and B. Leonard APOBEC3B is an enzymatic source of mutation in breast cancer Nature 494 2013 366 370
74. A.H. Teh, M. Kimura, M. Yamamoto, N. Tanaka, I. Yamaguchi, and T. Kumasaka The 1.48 Å resolution crystal structure of the homotetrameric cytidine deaminase from mouse Biochemistry 45 2006 7825 7833
75. W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, and M.L. Klein Comparison of simple potential functions for simulating liquid water J Chem Phys 79 1983 926 935
76. Y.P. Pang Novel zinc protein molecular dynamics simulations: steps toward antiangiogenesis for cancer treatment J Mol Model 5 1999 196 202
77. R. Rodriguez, G. Chinea, N. Lopez, T. Pons, and G. Vriend Homology modeling, model and software evaluation: three related resources Bioinformatics 14 1998 523 528
78. V.B. Chen, W.B. Arendall, J.J. Headd, D.A. Keedy, R.M. Immormino, and G.J. Kapral MolProbity: all-atom structure validation for macromolecular crystallography Acta Crystallogr Sect D Biol Crystallogr 66 2010 12 21
79. V. Hornak, R. Abel, A. Okur, B. Strockbine, A. Roitberg, and C. Simmerling Comparison of multiple Amber force fields and development of improved protein backbone parameters Proteins 65 2006 712 725
80. J.C. Phillips, R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid, and E. Villa Scalable molecular dynamics with NAMD J Comput Chem 26 2005 1781 1802
81. A.W. Gotz, M.J. Williamson, D. Xu, D. Poole, S. Le Grand, and R.C. Walker Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized Born J Chem Theory Comput 8 2012 1542 1555